Beovu 120 mg/ml solution for injection in pre-filled syringe

Active Ingredient:

brolucizumab

Company:

Novartis Pharmaceuticals UK Ltd See contact details

ATC code:

S01LA06

About Medicine

${medical_services}$

Prescription only medicine

My Account Area

${arrow_down}$

Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs Audio/Video HCP Med Info

${arrow_left}$

${arrow_right}$

Beovu Patient Guide to Therapy - for patients with visual impairment due to DMO - Audio Version

This audio has been produced by Novartis Pharmaceutical Limited. Your guide to therapy with Beovu (brolucizumab) – for the treatment of patients with visual impairment due to Diabetic Macular Oedema (DMO).

Beovu Patient Guide to Therapy - Audio Version for patients with wet AMD

This audio has been produced by Novartis Pharmaceutical Limited. Your guide to therapy with Beovu (brolucizumab) – for the treatment of neovascular (wet) age-related macular degeneration (AMD).